<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors present an account of the therapeutic results with small doses of <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi>--20 mg/m2/day--in 56 patients where in almost 10% of the patients long-term "complete" remission was achieved and in 22% partial remission </plain></SENT>
<SENT sid="1" pm="."><plain>When very small doses were used, i.e. 5 mg/m2/day, only one partial remission was achieved in a total number of 10 patients </plain></SENT>
<SENT sid="2" pm="."><plain>From analysis of the therapeutic results some practical conclusions can be drawn which are listed in the discussion </plain></SENT>
<SENT sid="3" pm="."><plain>So far we do not know effective treatment of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and recommend therefore to test in suitable patients small doses of ARA-C, despite the fact that a favourable response to this treatment can be expected only in about one third of the patients </plain></SENT>
</text></document>